Literature DB >> 16025143

Mechanisms of the anti-inflammatory effects of the natural secosteroids physalins in a model of intestinal ischaemia and reperfusion injury.

Angélica T Vieira1, Vanessa Pinho, Lucilia B Lepsch, Cristóforo Scavone, Ivone M Ribeiro, Therezinha Tomassini, Ricardo Ribeiro-dos-Santos, Milena B P Soares, Mauro M Teixeira, Danielle G Souza.   

Abstract

Reperfusion of an ischaemic tissue is associated with an intense inflammatory response and inflammation-mediated tissue injury. Physalins, a group of substances with secosteroidal chemical structure, are found in Physalis angulata stems and leaves. Here, we assessed the effects of physalins on the local, remote and systemic injuries following intestinal ischaemia and reperfusion (I/R) in mice and compared with the effects of dexamethasone. Following I/R injury, dexamethasone (10 mg kg(-1)) or physalin B or F markedly prevented neutrophil influx, the increase in vascular permeability in the intestine and the lungs. Maximal inhibition occurred at 20 mg kg(-1). Moreover, there was prevention of haemorrhage in the intestine of reperfused animals. Dexamethasone or physalins effectively suppressed the increase in tissue (intestine and lungs) and serum concentrations of TNF-alpha. Interestingly, treatment with the compounds was associated with enhancement of IL-10. The anti-inflammatory effects of dexamethasone or physalins were reversed by pretreatment with the corticoid receptor antagonist RU486 (25 mg kg(-1)). The drug compounds suppressed steady-state concentrations of corticosterone, but did not alter the reperfusion-associated increase in levels of corticosterone. The IL-10-enhancing effects of the drugs were not altered by RU486. In conclusion, the in vivo anti-inflammatory actions of physalins, natural steroidal compounds, appear to be mostly due to the activation of glucocorticoid receptors. Compounds derived from these natural secosteroids may represent novel therapeutic options for the treatment of inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16025143      PMCID: PMC1576270          DOI: 10.1038/sj.bjp.0706321

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  45 in total

Review 1.  Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways.

Authors:  L I McKay; J A Cidlowski
Journal:  Endocr Rev       Date:  1999-08       Impact factor: 19.871

2.  Significance of enhanced cytokine receptor expression by glucocorticoids.

Authors:  W Y Almawi; D A Hess; M J Rieder
Journal:  Blood       Date:  1998-11-15       Impact factor: 22.113

Review 3.  Pathophysiology of ischaemia-reperfusion injury.

Authors:  D L Carden; D N Granger
Journal:  J Pathol       Date:  2000-02       Impact factor: 7.996

Review 4.  Ischemia-reperfusion: mechanisms of microvascular dysfunction and the influence of risk factors for cardiovascular disease.

Authors:  D N Granger
Journal:  Microcirculation       Date:  1999-09       Impact factor: 2.628

5.  Effects of a BLT receptor antagonist on local and remote reperfusion injuries after transient ischemia of the superior mesenteric artery in rats.

Authors:  D G Souza; S F Coutinho; M R Silveira; D C Cara; M M Teixeira
Journal:  Eur J Pharmacol       Date:  2000-09-01       Impact factor: 4.432

Review 6.  Actions of glucocorticosteroids on ischemic-reperfused muscle and cutaneous tissue.

Authors:  A V Korompilias; L E Chen; A V Seaber; J R Urbaniak
Journal:  Microsurgery       Date:  1996       Impact factor: 2.425

7.  Glucocorticoids up-regulate constitutive interleukin-10 production by human monocytes.

Authors:  L Mozo; A Suárez; C Gutiérrez
Journal:  Clin Exp Allergy       Date:  2004-03       Impact factor: 5.018

Review 8.  Anti-inflammatory actions of glucocorticoids: molecular mechanisms.

Authors:  P J Barnes
Journal:  Clin Sci (Lond)       Date:  1998-06       Impact factor: 6.124

9.  Glucocorticoids inhibit superoxide anion production and p22 phox mRNA expression in human aortic smooth muscle cells.

Authors:  T Marumo; V B Schini-Kerth; R P Brandes; R Busse
Journal:  Hypertension       Date:  1998-12       Impact factor: 10.190

10.  Glucocorticoids increase IL-10 expression in multiple sclerosis patients with acute relapse.

Authors:  A Gayo; L Mozo; A Suárez; A Tuñon; C Lahoz; C Gutiérrez
Journal:  J Neuroimmunol       Date:  1998-05-15       Impact factor: 3.478

View more
  12 in total

1.  Differential effects of nutritional and non-nutritional therapies on intestinal barrier function in an in vitro model.

Authors:  Lily Nahidi; Andrew S Day; Daniel A Lemberg; Steven T Leach
Journal:  J Gastroenterol       Date:  2011-09-28       Impact factor: 7.527

2.  4β-Hydroxywithanolide E isolated from Physalis pruinosa calyx decreases inflammatory responses by inhibiting the NF-κB signaling in diabetic mouse adipose tissue.

Authors:  T Takimoto; Y Kanbayashi; T Toyoda; Y Adachi; C Furuta; K Suzuki; T Miwa; M Bannai
Journal:  Int J Obes (Lond)       Date:  2014-02-25       Impact factor: 5.095

3.  HMGB1-TLR4 signaling participates in renal ischemia reperfusion injury and could be attenuated by dexamethasone-mediated inhibition of the ERK/NF-κB pathway.

Authors:  Jiong Zhang; Jumei Xia; Ying Zhang; Fang Xiao; Jin Wang; Hongyu Gao; Yanyan Liu; Song Rong; Ying Yao; Gang Xu; Junhua Li
Journal:  Am J Transl Res       Date:  2016-10-15       Impact factor: 4.060

4.  Ischemic post-conditioning to counteract intestinal ischemia/reperfusion injury.

Authors:  Yan-Fang Guan; Timothy A Pritts; Marshall H Montrose
Journal:  World J Gastrointest Pathophysiol       Date:  2010-10-15

5.  Contribution of Cage-Shaped Structure of Physalins to Their Mode of Action in Inhibition of NF-κB Activation.

Authors:  Masaaki Ozawa; Masaki Morita; Go Hirai; Satoru Tamura; Masao Kawai; Ayako Tsuchiya; Kana Oonuma; Keiji Maruoka; Mikiko Sodeoka
Journal:  ACS Med Chem Lett       Date:  2013-06-06       Impact factor: 4.345

Review 6.  Therapeutic Applications of Physalins: Powerful Natural Weapons.

Authors:  Cássio Santana Meira; José Waldson Capinan Soares; Bruna Padilha Zurita Claro Dos Reis; Luciano Vasconcellos Pacheco; Ivanilson Pimenta Santos; Dahara Keyse Carvalho Silva; Julia Costa de Lacerda; Sérgio Ricardo Teixeira Daltro; Elisalva Teixeira Guimarães; Milena Botelho Pereira Soares
Journal:  Front Pharmacol       Date:  2022-04-05       Impact factor: 5.988

7.  Epithelial NAIPs protect against colonic tumorigenesis.

Authors:  Ramanjaneyulu Allam; Michel H Maillard; Aubry Tardivel; Vijaykumar Chennupati; Hristina Bega; Chi Wang Yu; Dominique Velin; Pascal Schneider; Kendle M Maslowski
Journal:  J Exp Med       Date:  2015-03-02       Impact factor: 14.307

8.  Synthesis of the Right-Side Structure of Type B Physalins.

Authors:  Masaki Morita; Shuntaro Kojima; Megumi Ohkubo; Hiroyuki Koshino; Daisuke Hashizume; Go Hirai; Keiji Maruoka; Mikiko Sodeoka
Journal:  Isr J Chem       Date:  2016-11-09       Impact factor: 3.333

9.  Intestinal anti-inflammatory activity of Ground Cherry (Physalis angulata L.) standardized CO2 phytopharmaceutical preparation.

Authors:  Luiz Domingues Almeida Junior; Ana Elisa Valencise Quaglio; Celso Acácio Rodrigues de Almeida Costa; Luiz Claudio Di Stasi
Journal:  World J Gastroenterol       Date:  2017-06-28       Impact factor: 5.742

Review 10.  Natural Products from Physalis alkekengi L. var. franchetii (Mast.) Makino: A Review on Their Structural Analysis, Quality Control, Pharmacology, and Pharmacokinetics.

Authors:  Jing Yang; Yanping Sun; Feng Cao; Bingyou Yang; Haixue Kuang
Journal:  Molecules       Date:  2022-01-21       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.